Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 22;22(1):22.
doi: 10.1186/2008-2231-22-22.

Synthesis, analgesic and anti-inflammatory activities of new methyl-imidazolyl-1,3,4-oxadiazoles and 1,2,4-triazoles

Ali Almasirad  1 , Zahra Mousavi, Mohammad Tajik, Mohammad Javad Assarzadeh, Abbas Shafiee
Affiliations

Synthesis, analgesic and anti-inflammatory activities of new methyl-imidazolyl-1,3,4-oxadiazoles and 1,2,4-triazoles

Ali Almasirad et al. Daru. .

Abstract

Background: Long-term clinical employment of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with significant side effects including gastrointestinal (GI) lesions and kidney toxicity. In this paper we designed and synthesized new imidazolyl-1,3,4-oxadiazoles and 1,2,4-triazoles by molecular hybridization of previously described anti-inflammatory compounds in the hope of obtaining new safer analgesic and anti-inflammatory agents.

Methods: The target structures were synthesized by preparation of 5-methyl-1H-imidazole-4-carboxylic acid ethyl ester 5. The reaction of hydrazine hydrate with this ester afforded the 5-methyl-1H-imidazole-4-carboxylic acid hydrazide 6 which was converted to target compounds 7-15 according to the known procedures. In silico toxicity risk assessment and drug likeness predictions were done, in order to consider the privileges of the synthesized structures as drug candidates.

Results and discussion: The analgesic and anti-inflammatory profile of the synthesized compounds were evaluated by writhing and carrageenan induced rat paw edema tests respectively. Compounds 8, 9 and 11-13 and 15 were active analgesic agents and compounds 8, 9 and 11-13 showed significant anti-inflammatory response in comparison with control. Compounds 11 and 13 were screened for their ulcerogenic activities and none of them showed significant ulcerogenic activity. The active Compounds 11 and 12 showed the highest drug likeness and drug score.

Conclusions: The analgesic and anti-inflammatory activities of title compounds were comparable to that of standard drug indomethacin with a safer profile of activity. The results revealed that both of oxadiazole and triazole scaffolds can be determined as pharmacophores. The in silico predictions and pharmacological evaluations showed that compounds 11 and 12 can be chosen as lead for further investigations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of compounds 1 and 2 as dual COX/5-LO inhibitors and anti-inflammatory agents.
Scheme 1
Scheme 1
Synthesis of hydrazide 6. (a) CH3COOH, NaNO2, 0°C; (b) HCHO, HCl, 0-5°C; NH3, 70°C; (c) NH2NH2.H2O, EtOH, reflux.
Scheme 2
Scheme 2
Synthesis of target derivatives 7–15. (a) BrCN, Dioxane, rt; (b) CS2, KOH, EtOH, reflux; (c) 1,1′-CDI, triethylamine, DMF, reflux; (d) (1) KSCN, HCl, H2O, rt; (2) NaOH 3%, 60-70°C; (e) (1) Isothiocyanate derivatives, EtOH, rt; (2) NaOH, reflux.
See this image and copyright information in PMC

References

    1. Gonzalez-Periz A, Claria J. New approaches to the modulation of the cyclooxygenase-2 and 5-lipoxygenase pathways. Curr Top Med Chem. 2007;7(3):297–309. doi: 10.2174/156802607779941378. - DOI - PubMed
    1. Pontiki E, Hadjipavlou-Litina D, Litinas K, Nicolotti O, Carotti A. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities. EurJ Med Chem. 2011;46(1):191–200. doi: 10.1016/j.ejmech.2010.10.035. - DOI - PubMed
    1. Eleftheriou P, Geronikaki A, Hadjipavlou-Litina D, Vicini P, Filz O, Filimonov D, Poroikov V, Shailendra S, Chaudhaery E, Roy KK, Saxena AK. Fragment-based design, docking, synthesis, biological evaluation and structure–activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. Eur J Med Chem. 2012;47:111–124. - PubMed
    1. Geronikaki AA, Lagunin AA, Hadjipavlou-Litina DI, Eleftheriou PT, Filimonov DA, Poroikov VV, Alam I, Saxena AA. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. J Med Chem. 2008;51(6):1601–1609. doi: 10.1021/jm701496h. - DOI - PubMed
    1. Celotti F, Laufer S. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept. Pharm Res. 2001;43(5):429–436. doi: 10.1006/phrs.2000.0784. - DOI - PubMed

LinkOut - more resources